Displaying items by tag:

UAB is part of several trials to test whether an infusion of antibodies from people who have beaten COVID-19 can help those dealing with infection or at risk for infection. Donors are needed.

Trial to rapidly identify and treat the immune overreaction that may be behind some cases of severe COVID-19 is made possible through UAB Medicine’s Urgent COVID-19 Clinical Research and Laboratory Research Fund.

Lab-grown human heart tissue could mean better drug tests, faster transplants and more accurate models of disease. To get there, Palaniappan Sethu, Ph.D., is stretching ingenuity.

UAB algorithm offers doctors a step-by-step guide to connect patients with HIV to best smoking-cessation options.

Are there differences in the way that minority groups and people with low socioeconomic status experience chronic low back pain? Learn more about an ongoing study in this new series that looks behind the scenes of UAB’s latest grants and contracts.

In a talk at UAB on March 6, the NIH director shared his thoughts on exceptional opportunities for science and young scientists — and highlighted several exciting UAB projects.

Learn how UAB researchers are taking on the most feared complication of the new generation of blood-thinning drugs. 

UAB-led study finds that genetic variations associated with cognitive decline after BMT identify high-risk patients more accurately than current methods.

Go behind the scenes of UAB’s latest grants and contracts in this new series to discover a fresh approach to treat an autoimmune disease and its mysterious double-negative B cells.

Nephrologist Ashita Tolwani, M.D., is internationally renowned for her expertise in continuous renal replacement therapy. UAB’s CRRT Queen explains this powerful, complex therapy and how UAB became a global leader in the field.

An innovative study led by Luciano Costa, M.D., Ph.D., generated national buzz for its success in beating back blood cancer — and enrolling African American patients.

Investigators attract major grants to use AI on failed drug trials, cell-free DNA and puzzling CT scans.

Single-cell sequencing enables researchers to study disease as never before — even skipping through time to follow crucial populations. UAB experts explain what all the fuss is about and how to get started in single-cell research — a field that is wide open for discovery.

A new textbook by Randy Cron, M.D., Ph.D., the first of its kind, can help physicians diagnose and treat an often-puzzling condition with a host of causes.

Five faculty are translating proven methods directly from Birmingham to locations around the world with pilot funding from the Sparkman Center for Global Health.

Monica Baskin, professor of preventive medicine, is the winner of the 2019 Odessa Woolfolk Community Service Award for her work to influence change in the field of health disparities action and research.

Gustavo “Tavo” Heudebert, M.D., interim dean of the UAB School of Medicine Montgomery Regional Medical Campus, is the recipient of the highest award for teaching presented by UAB. He will be recognized during the Faculty Convocation Sept. 10.

Faculty at UAB developed Rigor, Reproducibility and Transparency to draw attention to common lab mistakes. The gamified online course has spread to 15 insitutions and counting.

Tina Kempin Reuter, Ph.D., and Professor Greg Pence, Ph.D., will carry the mace in the graduate and undergraduate ceremonies, respectively.

The winning proposal is a comprehensive approach to fixing Alabama’s complex health problems and includes 90 partners from government, business, education and more.

Curtis is co-director of the UAB Center for Education and Research on Therapeutics of Musculoskeletal Disorders and associate scientist in the UAB Center for Metabolic Bone Disease.

Nurse practitioner details physical, emotional toll of disease in A Place I Didn't Want to Go: My Victory Over Cancer.

Seven awarded endowed professorship; four are inaugural holders

UAB and Birmingham stepped up to fight the virus that causes AIDS years ago when it could have easily turned away

Traveler's Health Clinic Director David Freedman says concerns the Germany strain of E. Coli will spread in America are minimal.

Page 2 of 3